1. Home
  2. BIO vs GSAT Comparison

BIO vs GSAT Comparison

Compare BIO & GSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$319.48

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Logo Globalstar Inc.

GSAT

Globalstar Inc.

HOLD

Current Price

$65.38

Market Cap

7.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
GSAT
Founded
1952
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Telecommunications Equipment
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
7.5B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
BIO
GSAT
Price
$319.48
$65.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$358.50
$52.75
AVG Volume (30 Days)
156.6K
1.1M
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,557,500,000.00
$262,202,000.00
Revenue This Year
$1.89
$10.89
Revenue Next Year
$2.45
$10.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.54
52 Week Low
$211.43
$17.24
52 Week High
$373.69
$65.52

Technical Indicators

Market Signals
Indicator
BIO
GSAT
Relative Strength Index (RSI) 52.57 67.65
Support Level $298.35 $58.02
Resistance Level $328.07 $62.68
Average True Range (ATR) 10.38 3.88
MACD 0.29 -0.18
Stochastic Oscillator 60.79 99.40

Price Performance

Historical Comparison
BIO
GSAT

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. It has one reportable segment: MSS business. The company generates the vast majority of its revenue within the United States.

Share on Social Networks: